These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34571102)

  • 1. Familial Hypercholesterolemia (FH) Registry Worldwide: A Systematic Review.
    Amerizadeh A; Javanmard SH; Sarrafzadegan N; Vaseghi G
    Curr Probl Cardiol; 2022 Oct; 47(10):100999. PubMed ID: 34571102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia.
    Jasani R; Ahmad Z; Schneider R; Tujardon C; Basit M; Khera A
    J Clin Lipidol; 2022; 16(4):508-515. PubMed ID: 35568683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries.
    Florentin M; Kostapanos MS; Elisaf MS; Liberopoulos EN
    Curr Pharm Des; 2018; 24(31):3605-3615. PubMed ID: 30306861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India.
    Sawhney JPS; Prasad SR; Sharma M; Madan K; Mohanty A; Passey R; Mehta A; Kandpal B; Makhija A; Jain R; Mantri RR; Vivek BS; Manchanda SC; Verma IC
    Indian Heart J; 2019; 71(2):118-122. PubMed ID: 31280822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
    Reddy LL; Shah SAV; Ashavaid TF
    Indian Heart J; 2022; 74(1):1-6. PubMed ID: 34875256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.
    Brown EE; Byrne KH; Davis DM; McClellan R; Leucker T; Jones SR; Martin SS
    J Clin Lipidol; 2020; 14(3):331-338. PubMed ID: 32220565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit.
    Pang J; Poulter EB; Bell DA; Bates TR; Jefferson VL; Hillis GS; Schultz CJ; Watts GF
    J Clin Lipidol; 2015; 9(5):703-8. PubMed ID: 26350818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
    Al-Rasadi K; Alhabib KF; Al-Allaf F; Al-Waili K; Al-Zakwani I; AlSarraf A; Almahmeed W; AlSayed N; Alghamdi M; Batais MA; Almigbal TH; Alnouri F; Kinsara A; Hammouda A; Awan Z; Kary H; Elamin OA; Zadjali F; Al-Jarallah M; Shehab A; Sabbour H; Amin H; Altaradi H
    Curr Vasc Pharmacol; 2020; 18(1):57-64. PubMed ID: 30289081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):200-204. PubMed ID: 29278517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.